510(k) Report

510(k) · Cleared

Cleared

Powder Free Nitrile Examination Gloves (Blue), Tested for Use with Chemotherapy Drugs

K211604510(k) TraditionalCleared Oct 27, 2021155-day reviewClass I21 CFR 880.6250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Shanxi Hongjin Plastic Technology Co., Ltd. · LZA Polymer Patient Examination Glove

Cleared on Oct 27, 2021 as substantially equivalent to K182600 (Better Care Plastic Technology Co., Ltd., 2018) after a 155-day review. Its family tree reaches back 7 generations to 2004.

Decided
Oct 27, 2021
Review
155 days
Class
Class I
Product code
LZA
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to K042805 (2004). 8 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 7 generations backK042805 Powder Free Nitrile Patient Examination Gloves, Blue Colored…Perusahaan Getah Asas Sdn. Bhd. · 2004
  2. 6 generations backK081089 Kimberly-Clark Sterling Nitrile & Nitrile-Xtra Powder-Free Exam…Kimberly-Clark Corp. · 2008
  3. 5 generations backK141982 Dermagrip Powder Free Blue Nitrile Patient Examination Gloves…Wrp Asia Pacific Sdn. Bhd. · 2015
  4. 4 generations backK163146 POWDER FREE Blue Nitrile GLOVES, Tested for Use with Chemotherapy…Hebei Hongsen Plastics Technology Co, Ltd. · 2017
  5. 3 generations backK172525 Blue Non Sterile Powder Free Nitrile Examination Gloves Tested for…Central Medicare Sdn Bhd · 2017
  6. 2 generations backK173942 Blue Non Sterile powder free Nitrile Examination Gloves Tested for…Central Medicare Sdn Bhd · 2018
  7. 1 generation backK182600 Powder Free Nitrile Examination Glove, Tested for Use with…Better Care Plastic Technology Co., Ltd. · 2018
  8. This deviceK211604 Powder Free Nitrile Examination Gloves (Blue), Tested for Use with…Shanxi Hongjin Plastic Technology Co., Ltd. · 2021
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K042805Powder Free Nitrile Patient Examination Gloves, Blue Colored Non-SterilePerusahaan Getah Asas Sdn. Bhd.2004—
−6K081089Kimberly-Clark Sterling Nitrile & Nitrile-Xtra Powder-Free Exam Gloves with…Kimberly-Clark Corp.2008—
−5K141982Dermagrip Powder Free Blue Nitrile Patient Examination Gloves, Non-Sterile…Wrp Asia Pacific Sdn. Bhd.2015—
−4K163146POWDER FREE Blue Nitrile GLOVES, Tested for Use with Chemotherapy DrugsHebei Hongsen Plastics Technology Co, Ltd.2017—
−3K172525Blue Non Sterile Powder Free Nitrile Examination Gloves Tested for Use with…Central Medicare Sdn Bhd2017—
−2K173942Blue Non Sterile powder free Nitrile Examination Gloves Tested for Use with…Central Medicare Sdn Bhd2018—
−1K182600Powder Free Nitrile Examination Glove, Tested for Use with Chemotherapy Drugs…Better Care Plastic Technology Co., Ltd.2018—
0 (this device)K211604Powder Free Nitrile Examination Gloves (Blue), Tested for Use with…Shanxi Hongjin Plastic Technology Co., Ltd.2021—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200510
FIG. 1 — Lineage of K211604, 2004–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZA device

  1. #1 K192333 Blue Nitrile Examination Gloves Powder Freescore 71.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K182600Powder Free Nitrile Examination Glove, Tested for Use with Chemotherapy Drugs (Blue)
Summary page 5
…Class I 3. Predicate Device Information: Better Care Plastic Technology Co., Ltd Powder Free Nitrile Examination Gloves, Tested for Use with Chemotherapy Drugs (Blue) (K182600) 4. Device Description: Powder Free Nitrile Examination Gloves(Blue), Tested for Use with Chemotherapy Drugs are Class I Patient…
Better Care Plastic Technology Co., Ltd.2018—

Also cleared against K182600: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 7 companies; a new generation was cleared every 2.0 years on median.
  • None of the 8 ancestors has a recall.
  • 2 other devices also cite its predicate K182600.

How does its category compare?

All LZA devices

LZA Polymer Patient Examination Glove: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · LZA

24in 2025

2007: 212008: 182009: 282010: 312011: 262012: 332013: 202014: 272015: 202016: 302017: 442018: 222019: 252020: 302021: 1392022: 1462023: 622024: 302025: 242026 (partial year): 15
2007high 146 (2022) · low 18 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZA

110in 2025

2007: 95 days median2008: 97 days median2009: 112 days median2010: 97 days median2011: 122 days median2012: 110 days median2013: 130 days median2014: 197 days median2015: 112 days median2016: 171 days median2017: 124 days median2018: 178 days median2019: 212 days median2020: 101 days median2021: 111 days median2022: 111 days median2023: 92 days median2024: 89 days median2025: 110 days median2026 (partial year): 103 days median
2007high 212 (2019) · low 89 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZA

3so far in 2026, the most since 2007

2015: 12016: 12026 (partial year): 3
2007high 3 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LZA

73in 2025

2007: 72008: 22009: 122010: 122011: 92012: 112013: 102014: 82015: 122016: 252017: 42018: 32019: 212020: 42021: 202022: 192023: 242024: 762025: 73
2007high 76 (2024) · low 2 (2008)2025

MAUDE reports naming product code LZA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007219507
2008189702
200928112012
20103197012
20112612209
201233110011
201320130010
20142719708
201520112112
201630171125
20174412404
20182217803
201925212021
20203010104
2021139111020
2022146111019
20236292024
20243089076
202524110073
2026151033—

What is it indicated for?

Powder Free Nitrile Examination Gloves (Blue), Tested for Use with Chemotherapy Drugs is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. Gloves have been tested for use with chemotherapy drugs using ASTM D6978 and will be labeled with a statement of compliance and a summary of the testing results. Chemotherapy Drug Permeation The following chemicals have been…

Read the full statement (241 words)

Powder Free Nitrile Examination Gloves (Blue), Tested for Use with Chemotherapy Drugs is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner.

Gloves have been tested for use with chemotherapy drugs using ASTM D6978 and will be labeled with a statement of compliance and a summary of the testing results.

Chemotherapy Drug Permeation

The following chemicals have been tested with these gloves:

* Please note that the following drugs have extremely low permeation times:

Chemotherapy Drug Minimum BDT (Minutes)

Bleomycin (15.0mg/ml) >240

Bortezomib (Velcade) lmg/ml >240

Busulfan (6.0mg/ml) >240

Carboplatin, (10.0mg/ml) >240

Carmustine(BCNU) (3.3 mg/ml) 7.0

Chloroquine, (50.0mg/ml) >240

Cisplatin (lmg/ml) >240

Cyclophosphamide (Cytoxan) (20mg/ml) >240

Cyclosporin, (100.Omg/ml) >240

Cytarabine, (100.0mg/ml) >240

Dacarbazine (10mg/ml) >240

Daunorubicin, HCL (5.Omg/ml) >240

Docetaxel, (10.Omg/ml) >240

Doxorubicin HCL (2mg/ml) >240

Epirubicin HCL (Ellence), (2.0mg/ml) >240

Etoposide (20mg/ml) >240

Fludarabine, (25.0mg/ml) >240

Fluorouracil (50mg/ml) >240

Gemcitabine (38.0mg/ml) >240

Idarubicin HCL (1.0mg/ml) >240

Ifosfamide, (50.Omg/ml) >240

Irinotecan, (20.0mg/ml) >240

Mechlorethamine HCI, (1.0mg/ml) >240

Melphalan, (5.0mg/ml) >240

Methotrexate (25mg/ml) >240

Mitomycin C, (0.5mg/ml) >240

Mitoxantrone, (2.0mg/ml) >240

Oxaliplatin, (5.Omg/ml) >240

Paclitaxel (Taxol) (6mg/ml) >240

Paraplatin, (10.0mg/ml) >240

Retrovir, (10.0mg/ml) >240

Rituximab, (10.0mg/ml) >240

Thio Tepa (10mg/ml) 23.0

Topotecan HCL, (1.0mg/ml) >240

Trisonex, (1.0mg/ml) >240

Vincristine, (1.0mg/ml) >240

Please note that the following drugs have extremely low permeation times:

Carmustine (BCNU): 7.0 minutes, Thio Tepa: 23 minutes,

Warning: Do not use with Carmustine (BCNU) and Thio Tepa.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K211604: Powder Free Nitrile Examination Gloves (Blue), Tested for Use with Chemotherapy Drugs.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K211604

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026